RUDN is developing partnerships with Medis pharmaceutical company (Tunisia)

RUDN is developing partnerships with Medis pharmaceutical company (Tunisia)

RUDN Center for Collective Use (CCU) begins joint development in the field of pharmacy and personnel training with Medis. The parties discussed issues of cooperation during the visit of Rimma Abramovich, director of the CCU, to the company's plant in Tunisia.

RUDN CCU strengthens international cooperation with foreign companies. The successful experience of the “full cycle” from pharmaceutical development to the commercialization of the finished medicinal product with Medis has become a platform for new ideas and plans of partner organizations.

The interest of the Tunisian company was evoked by the ongoing projects of RUDN in the field of personalized medicine and the possibility of conducting research on bioequivalence based on the CCU and clinical trials of oncological drugs based on the project partners’ sites (Moscow Herzen Research Oncological Institute).

The CCU can in the future serve as a platform for the implementation of the “industrial” PhD program, having a modern instrumentation park and a training

and production site with a license to produce drugs: the company sends its employee to graduate school, after graduation the employee returns and implements the results of his or her research in production. At the moment, agreements have been reached on the exchange of scientific knowledge in the field of X-ray diffraction analysis, NMR spectroscopy, melt extrusion, and metabolomics in online consultation mode and in the framework of further education programs.

News
All news
Science
27 Apr
Vocabulary Size Affects One’s Ability to Differentiate Between Vowels in a Foreign Language, Say Linguists from RUDN University

A team of linguists from RUDN University established that a person’s ability to accurately differentiate between vowel sounds of a foreign language correlates with the size of their vocabulary in said language.

Science
22 Apr
A Bifidobacterial Protein Capable of Reducing Inflammation in Patients with COVID-19 and Other Diseases Was Discovered by a RUDN University Geneticist

A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID-19 patients. A fragment of this protein can be used as an anti-inflammatory medication when treating coronavirus and other diseases.

Science
13 Apr
RUDN University mathematician suggested new approach to cooperative game

A mathematician from RUDN University developed a matrix representation of set functions. This approach is vivid and easy to check, and it makes the calculations easier. Among other things, the new development can be applied to cooperative game theory.